A Multicenter, Randomized, Double-blinded, Placebo-controlled, Phase 3 Clinical Efficacy Study Evaluating Nitric Oxide Nasal Spray (NONS) as Prevention for Treatment of Individuals at Risk of Exposure to COVID-19 Infection
Latest Information Update: 09 May 2023
At a glance
- Drugs Nitric oxide (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors SaNOtize Research and Development
- 02 May 2023 Planned End Date changed from 30 Jul 2023 to 30 Apr 2024.
- 02 May 2023 Planned primary completion date changed from 30 Jul 2023 to 30 Jan 2024.
- 03 Nov 2022 Planned End Date changed from 30 Nov 2022 to 30 Jul 2023.